EAP M&A and Valuation Analyst
Raymond Vance studies the financial and operational factors that determine what an employee assistance program is truly worth. His interest in the industry began with a simple observation: many successful EAP owners understand how to build a clinically excellent, well-retained book of business, but few receive clear guidance on how buyers, investors, and private equity groups evaluate the companies they have created.
His work focuses on the numbers and structures behind EAP transactions, including adjusted EBITDA, revenue quality, PEPM contract terms, utilization economics, client and covered-lives concentration, renewal and churn history, broker channel dependence, employed versus affiliate clinical networks, buyer activity, deal terms, earnouts, and rollover equity. He translates these often-complex topics into practical information that owners can understand and use when planning for growth, evaluating an offer, or preparing for an eventual exit.
Raymond believes that an EAP owner should begin preparing for a sale long before speaking with a buyer. Contract quality, utilization trends, network structure, and financial reporting are not things that can be fixed in the weeks after a letter of intent arrives. The decisions that set a valuation are usually made two to three years earlier, quietly, by owners who did not yet know they were making them.
His goal is not to promote unrealistic valuations or quick-sale promises. It is to give employee assistance founders the same clarity that institutional buyers bring to the table — honest benchmarks, stated assumptions, and a plain account of what drives a number up or down — so that when the conversation finally happens, the owner is the best-informed person in the room.